Key result
Short-term blood pressure variability did not predict the composite renal endpoint of ESRD or ≥50% GFR decline in patients with chronic kidney disease (HR 0.97; 95% CI 0.91-1.04).
Why the study?
Does short-term blood pressure variability predict CKD progression in hypertensive patients with CKD?
Cohort (n=465)
Does short-term blood pressure variability predict CKD progression in hypertensive patients with CKD?
Hazard Ratio: 0.97 (95% CI 0.91–1.04)
Short-term blood pressure variability does not predict CKD progression in hypertensive patients with CKD, whereas absolute 24-hour, daytime, and night-time SBP are robust predictors.
Short-term BP variability adds no renal prognostic value in CKD; leaves open whether mean SBP-targeted strategies slow progression.
OBJECTIVE: In chronic kidney disease (CKD), few cross-sectional studies evidenced an association between short-term BP variability (BPV) derived from ambulatory blood pressure (ABP) monitoring and renal damage. However, no study has evaluated the association of short-term BPV with the risk of CKD progression. METHODS: We performed a cohort study to assess the correlates and the predictive value for incident renal outcomes of short-term BPV in hypertensive patients with CKD stage G1-5. As measures of short-term BPV, we considered the weighted SD (W-SD), and the coefficient of variation of SBP (CV-24-h SBP). Primary outcome was a composite endpoint of ESRD (chronic dialysis or transplantation) or GFR decline of at least 50%. RESULTS: We included 465 patients (63.5 ± 14.2 years; 54.7% men; eGFR: 44 ± 22 ml/min per 1.73 m; proteinuria: 0.2 [0.1-0.9] g/day); W-SD, CV-24-h SBP and 24 h SBP were 12.5 ± 3.3 mmHg, 11.1 ± 2.8% and 127 ± 16 mmHg, respectively. W-SD was independently associated with older age, history of cardiovascular disease, diagnosis of diabetic, hypertensive and polycystic nephropathy, and higher 24 h SBP whereas no association with eGFR and proteinuria was found. During follow-up (median, 6.4 years), 130 patients reached the renal outcome (107 ESRD and 23 GFR decline of ≥50%). Higher 24 h, daytime and night-time SBP robustly predicted the composite renal endpoint [1.18 (1.10-1.25) for 5 mmHg], whereas BPV as measured by the W-SD did not either when expressed as a continuous variable [hazard ratio 0.97 (95% CI 0.91-1.04)] or when categorized into tertiles [1.16 (0.70-1.92) and 0.95 (0.54-1.68) in II and III tertiles, respectively]. Similar findings were found with CV-24-h SBP. CONCLUSION: In CKD patients, short-term BPV is strongly associated with 24 h, night-time and daytime BP but is independent from the eGFR and proteinuria and does not predict CKD progression.
No takes yet. Share an insight, caveat, or question.
Borrelli et al. (2018) conducted a cohort in Chronic kidney disease (n=465). Short-term blood pressure variability was evaluated on Composite endpoint of ESRD (chronic dialysis or transplantation) or GFR decline of at least 50% (HR 0.97, 95% CI 0.91-1.04). Short-term blood pressure variability did not predict the composite renal endpoint of ESRD or ≥50% GFR decline in patients with chronic kidney disease (HR 0.97; 95% CI 0.91-1.04).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: